Although malignant pleural mesothelioma (MPM) is a rare tumor, it is among one the most discussed tumor in the industrial world. Mesothelioma represents 0.3% of all number of deaths for cancer in the recent GLOBOCAN study ( ). The incidence is projected to increase in the next two decades, and the reported dismal 5-year survival rate of less than 5% makes MPM one of the deathliest worldwide tumor ( , ). Some Scientists suggest that the asbestos promotes a chronic pleural inflammatory that after years stimulates the development of a malignant mesothelioma in up to 5% of exposed individuals ( ).
展开▼
